메뉴 건너뛰기




Volumn 26, Issue 8, 2012, Pages 1095-1098

Prevalence of nephrolithiasis in human immunodeficiency virus infected patients on the highly active antiretroviral therapy

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIVIRUS AGENT; ATAZANAVIR; CYSTINE; DARUNAVIR; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; EMTRICITABINE; INDINAVIR; LOPINAVIR; NELFINAVIR; NEVIRAPINE; RALTEGRAVIR; RITONAVIR; TENOFOVIR; URIC ACID; WHEWELLITE; ZIDOVUDINE;

EID: 84865196354     PISSN: 08927790     EISSN: 1557900X     Source Type: Journal    
DOI: 10.1089/end.2011.0639     Document Type: Article
Times cited : (9)

References (30)
  • 1
    • 17444377146 scopus 로고    scopus 로고
    • The urological management of the patient with acquired immunodeficiency syndrome
    • Heyns CF, Fisher M. The urological management of the patient with acquired immunodeficiency syndrome. BJU Int 2005;95:709-716.
    • (2005) BJU Int. , vol.95 , pp. 709-716
    • Heyns, C.F.1    Fisher, M.2
  • 2
    • 79959747720 scopus 로고    scopus 로고
    • Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy
    • Huynh J, Hever A, Tom T, Sim JJ. Indinavir-induced nephrolithiasis three and one-half years after cessation of indinavir therapy. Int Urol Nephrol 2011;43:571-573.
    • (2011) Int. Urol. Nephrol. , Issue.43 , pp. 571-573
    • Huynh, J.1    Hever, A.2    Tom, T.3    Sim, J.J.4
  • 3
    • 0037408101 scopus 로고    scopus 로고
    • Time trends in reported prevalence of kidney stones in the United States 1976-1994
    • Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63:1817-1823.
    • Kidney Int. , vol.2003 , Issue.63 , pp. 1817-1823
    • Stamatelou, K.K.1    Francis, M.E.2    Jones, C.A.3
  • 4
    • 0037305779 scopus 로고    scopus 로고
    • The etiology of urolithiasis in HIV infected patiends
    • Nadler RB, Rubenstein JN, Eggener SE, et al. The etiology of urolithiasis in HIV infected patiends. J Urol 2003;169:475-477.
    • (2003) J. Urol. , vol.169 , pp. 475-477
    • Nadler, R.B.1    Rubenstein, J.N.2    Eggener, S.E.3
  • 5
    • 13744257116 scopus 로고    scopus 로고
    • Urologic Diseases of America Project. Urologic Diseases of America project: Urolithiasis
    • Pearle MS, Calhoun EA, Curhan GC; Urologic Diseases of America Project. Urologic Diseases of America project: Urolithiasis. J Urol 2005;173:848-857.
    • (2005) J. Urol. , vol.173 , pp. 848-857
    • Pearle, M.S.1    Calhoun, E.A.2    Curhan, G.C.3
  • 6
    • 0021813989 scopus 로고
    • The current role of medical treatment of nephrolithiasis: The impact of improved techniques of stone removal
    • Preminger GM, Peterson R, Peters PC, Pak CY. The current role of medical treatment of nephrolithiasis: The impact of improved techniques of stone removal. J Urol 1985;134:6-10.
    • (1985) J. Urol. , vol.134 , pp. 6-10
    • Preminger, G.M.1    Peterson, R.2    Peters, P.C.3    Pak, C.Y.4
  • 7
    • 0035730509 scopus 로고    scopus 로고
    • The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome
    • Lee LK, Dinneen MD, Ahmad S. The urologist and the patient infected with human immunodeficiency virus or with acquired immunodeficiency syndrome. BJU Int 2001;88:500-510.
    • (2001) BJU Int. , vol.88 , pp. 500-510
    • Lee, L.K.1    Dinneen, M.D.2    Ahmad, S.3
  • 8
    • 0012938802 scopus 로고    scopus 로고
    • Recognizing the urologic manifestations of HIV and AIDS
    • Steele BW, Carson CC. Recognizing the urologic manifestations of HIV and AIDS. Contemp Urol 1997;9:39-53.
    • (1997) Contemp. Urol. , vol.9 , pp. 39-53
    • Steele, B.W.1    Carson, C.C.2
  • 9
    • 0032704120 scopus 로고    scopus 로고
    • Strategies of antiretroviral therapy in adults
    • Itani S, Bartlett JA. Strategies of antiretroviral therapy in adults. Urol Clin North Am 1999;26:809-820.
    • (1999) Urol Clin. North Am. , vol.26 , pp. 809-820
    • Itani, S.1    Bartlett, J.A.2
  • 11
    • 0033763935 scopus 로고    scopus 로고
    • Increased prevalence and analysis of risk factors for indinavir nephrolithiasis
    • Saltel E, Angel JB, Futter NG, et al. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis. J Urol 2000;164:1895-1897.
    • (2000) J. Urol. , vol.164 , pp. 1895-1897
    • Saltel, E.1    Angel, J.B.2    Futter, N.G.3
  • 12
    • 0030845902 scopus 로고    scopus 로고
    • Urolithiasis associated with the protease inhibitor indinavir
    • Bruce RG, Munch LC, Hoven AD, et al. Urolithiasis associated with the protease inhibitor indinavir. Urology 1997;50: 513-518.
    • (1997) Urology , vol.50 , pp. 513-518
    • Bruce, R.G.1    Munch, L.C.2    Hoven, A.D.3
  • 13
    • 0031965337 scopus 로고    scopus 로고
    • Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis
    • Witte M, Tobon A, Gruenefelder J, et al. Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis. J Urol 1998;159:498-499.
    • (1998) J. Urol. , vol.159 , pp. 498-499
    • Witte, M.1    Tobon, A.2    Gruenefelder, J.3
  • 18
    • 33750268789 scopus 로고    scopus 로고
    • Atazanavir urinary stones in an HIV-infected patient
    • Pacanowski J, Poirier JM, Petit I, et al. Atazanavir urinary stones in an HIV-infected patient. AIDS 2006;20:2131.
    • (2006) AIDS , vol.20 , pp. 2131
    • Pacanowski, J.1    Poirier, J.M.2    Petit, I.3
  • 19
    • 34347354196 scopus 로고    scopus 로고
    • Efficacy and safety of TMC125 (etravirine) in treatment experienced HIV-1- infected patients in DUET-2: 24 week results from a randomised, double-blind, placebo-controlled trial
    • Lazzarin A, Campbell T, Clotet B, et al. Efficacy and safety of TMC125 (etravirine) in treatment experienced HIV-1- infected patients in DUET-2: 24 week results from a randomised, double-blind, placebo-controlled trial. Lancet 2007; 370:39-48.
    • (2007) Lancet , vol.370 , pp. 39-48
    • Lazzarin, A.1    Campbell, T.2    Clotet, B.3
  • 20
    • 0029790554 scopus 로고    scopus 로고
    • Renal failure after treatment with ritonavir
    • Duong M, Sgro C, Grappin M, et al. Renal failure after treatment with ritonavir. Lancet 1996;348:693.
    • (1996) Lancet , vol.348 , pp. 693
    • Duong, M.1    Sgro, C.2    Grappin, M.3
  • 21
    • 0030970649 scopus 로고    scopus 로고
    • Pancreatorenal syndrome associated with combination antiretroviral therapy in HIV infection
    • Stricker RB, Man KM, Bouvier DB, et al. Pancreatorenal syndrome associated with combination antiretroviral therapy in HIV infection. Lancet 1997;349:1745-1746.
    • (1997) Lancet , vol.349 , pp. 1745-1746
    • Stricker, R.B.1    Man, K.M.2    Bouvier, D.B.3
  • 23
    • 48749104675 scopus 로고    scopus 로고
    • Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study
    • Young B, Buchacz K, Baker RK, et al. Renal function in Tenofovir-exposed and Tenofovir-unexposed patients receiving highly active antiretroviral therapy in the HIV Outpatient Study. J Int Assoc Physicians AIDS Care (Chic) 2007;6:178-187.
    • (2007) J. Int. Assoc. Physicians AIDS Care Chic , vol.6 , pp. 178-187
    • Young, B.1    Buchacz, K.2    Baker, R.K.3
  • 28
    • 49949098273 scopus 로고    scopus 로고
    • Same patient, new stone composition: Amprenavir urinary stone
    • Feicke A, Rentsch KM, Oertle D, Strebel RT. Same patient, new stone composition: Amprenavir urinary stone. Antivir Ther 2008;13:733-734.
    • (2008) Antivir. Ther. , vol.13 , pp. 733-734
    • Feicke, A.1    Rentsch, K.M.2    Oertle, D.3    Strebel, R.T.4
  • 29
    • 80051789059 scopus 로고    scopus 로고
    • Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir
    • Rockwood N, Mandalia S, Bower M, et al. Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir. AIDS 2011;25: 1671-1673.
    • (2011) AIDS , Issue.25 , pp. 1671-1673
    • Rockwood, N.1    Mandalia, S.2    Bower, M.3
  • 30
    • 0031718856 scopus 로고    scopus 로고
    • Renal calculi developing de novo in a patient taking saquinavir
    • Green ST, McKendrick MW, Schmid ML, et al. Renal calculi developing de novo in a patient taking saquinavir. Int J STD AIDS 1998;9:555.
    • (1998) Int. J. STD AIDS , vol.9 , pp. 555
    • Green, S.T.1    McKendrick, M.W.2    Schmid, M.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.